These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
5. The heart of the matter. National guidelines urge more aggressive cholesterol treatment. Leake NB Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511 [No Abstract] [Full Text] [Related]
6. [Lipid therapy. Goal and use in prevention of coronary heart disease]. Windler E; Greten H Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925 [No Abstract] [Full Text] [Related]
8. Cholesterol reduction therapy: a double-edged knife. Ong HT Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol in adolescents: whom to screen & how to treat. Kohn MR; Jacobson MS Compr Ther; 1996 Dec; 22(12):817-25. PubMed ID: 9030463 [No Abstract] [Full Text] [Related]
10. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
12. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously]. MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253 [No Abstract] [Full Text] [Related]
16. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]